Trial intelligence / Profile preview

Sunitinib in Advanced Soft Tissue Sarcoma

NCT00400569Phase 2Completed

Sponsor
Moffitt Cancer Center
Start
Nov 2006
Primary completion
Dec 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sunitinib in soft tissue sarcoma (STS), sponsored by Moffitt Cancer Center. Started Nov 2006; status: completed.

02

Drugs

sunitinib
03

Conditions

soft tissue sarcoma (STS)

Beyond the preview

Go deeper on NCT00400569.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00400569.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call